The Efficacy of Renin Inhibition on Progression and Regression of Hypercolesterolemia-Induced Atherosclerosis

Grants and Contracts Details

StatusFinished
Effective start/end date7/1/08 → 6/30/11

Funding

  • Novartis (domestic): $166,419.00